Viral Vectors
A Viral Vector CDMO Vision that Resonates
Drew Brennan; Chris Berger; Elie Hanania, Ph.D.; Dave Ingamells; Rami Barghout, PE
Avid Bioservices
PAO-03-24-CL-06Mar 14, 2024
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03Mar 14, 2023
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
Pramthesh (Prem) Patel, Ph.D.
Avid Bioservices
PAO-02-23-CL-06Mar 02, 2023
PLIs
A Strategic Approach to Pre-License Inspections
William Leonardi, Ph.D.
Avid Bioservices
PAO-11-022-CL-03Dec 15, 2022
Viral Vectors
Risk-Based Optimization of Viral Vector Processes Adds Real Value
Elie Hanania, Ph.D.; Tatiana Mello, M.S.
Avid Bioservices
PAO-09-022-CL-05Oct 25, 2022
Viral Vector Manufacturing
Avid Bioservices, Inc. and CRB Highlight Efforts that Enabled Opening of First Phase of New Viral Vector Facility in California in Only Eight Months
Avid Bioservices
PR-M06-22-05Jun 16, 2022
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
Avid Bioservices
PR-M06-22-02Jun 13, 2022
Board of Directors
Driving the Industry Forward on Multiple Boards
Jeanne Thoma
Avid Bioservices
PAO-06-22-R250-01Jun 01, 2022
Viral Vector Manufacturing
Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design
Chris Berger; Atef Khezri
Avid Bioservices
PAO-05-022-CL-02May 10, 2022
Biologics CDMO
Growing as a Trusted, Dedicated Commercial Biologics CDMO
Nicholas Green
Avid Bioservices
PAO-01-22-R250-02Jan 26, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734Dec 20, 2021
Process Development
Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.
Jeanette Doerr, Ph.D.; Haiou Yang, Ph.D.
Avid Bioservices
PAO-11-21-CL-02Nov 09, 2021
Gene Therapy
A Customer-Centric Approach to Cell and Gene Therapy Manufacturing
Drew Brennan
Avid Bioservices
PAO-10-21-CL-06Oct 13, 2021
Facility Expansion
Expanding and Serving the Market with Flexible Single-Use Capacity
Michael Alston, Jr.
Avid Bioservices
PAO-09-21-CL-09Sep 17, 2021
Quality
Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status
Ray Marzouk
Avid Bioservices
PAO-06-21-CL-12Jun 29, 2021
Strategic Growth
Unique Commercial Experience Primes Avid Bioservices for Growth
Nicholas Green
Avid Bioservices
PAO-05-21-CL-03May 12, 2021
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
Richard Richieri
Avid Bioservices
PAO-03-21-CL-03Mar 18, 2021
Single-Use Technology
Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT
Ryan MacDonald
Avid Bioservices
PAP-Q4-20-CL-004Dec 09, 2020
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
Nicholas Green
Avid Bioservices
PAP-Q3-20-CL-008Sep 29, 2020
Industry Leader Insight
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
Magnus Schroeder, Ph.D.
Avid Bioservices
PAP-Q2-20-CL-002Jul 01, 2020